Agenda day 1
1:00 pm
Registration and Coffee
| | |
2:00 pm
Opening remarks of the Chairman
Dr. Thomas Dries
Honeywell (DE)
Chairman of the Board, HCPC-Europe |
| |
2:10 pm
Reminder Packaging for Improving Adherence to Self-Administered
Long-Term Medications
| |
• |
Why is reminder packaging imporant? |
| |
• |
Summary of previous review |
| |
• |
New findings |
| |
• |
Future changes |
Dr. Kamal Mahtani BSc PhD MBBS
University of Oxford (UK) |
| |
2:50 pm
Patient "Compliance or Adherence" - What's in a Word? - Why Patient might not be "Compliant"
Sandy Craine
CML Support Group, ECPC (UK) |
| |
3:30 pm
Coffee Break
|
| |
4:20 pm
Pharmaceutical Packaging for the Benefit of Patients and Healthcare Professionals: EMA Perspective
|
• |
Leagal requirements |
|
• |
How does EMA look at/evaluate the packaging |
|
• |
Patient safety: compliance and medication errors |
|
• |
How to reconcile national practices at European level |
|
• |
Challenges:
- Size of packaging versus multilingual labelling
- Packaging adepted to the patient's condition
- differentiation within a range
|
Dr. Isabelle Moulon
EMA (UK) |
| |
5:00 pm
Driving Patient Adherence by Packaging Solutions
Tassilo Korab
Executive Director, HCPC-Europe |
| |
5:40 pm
Closing Words
|
| |
7:30 pm
Welcome Cocktail
|
| |
8:00 pm
Networking Dinner
| | |
Agenda day 2
9:00 am
Opening Remarks day 2
| | |
09:10 am
Enhancing Patient Treatment Compliance with Product Specifications
| |
• |
Patient viewpoint on compliance |
| |
• |
Compliance improvement with product specification |
| |
• |
Opportunities for pharmaceutical companies |
Peter Behner
Booz & Companies (DE) |
| |
09:50 am
What is the Pharmaceutical Industries' Interest in Improved Patient Compliance/Adherence?
|
• |
Why the pharmaceutical industry is interested in patient compliance - from a business and corporate responsibility perspective |
|
• |
What do we know about the extent of poor adherence to medicines and what is its impact on health outcomes? |
|
• |
How can the pharmaceutical industry understand the real barriers patients have to medication compliance and self-management? |
|
• |
What are sustainable ways by which the pharmaceutical industry can help improve patient compliance and self-management? |
Søren Skovlund
Novo Nordisk (DK) |
| |
10:30 am
Coffee Break
|
| |
11:10 am
Adherence Monitoring in Chronic Injectable Therapy
| |
• |
How to achieve adherence monitoring with injectable therapy |
| |
• |
Establishing the importance adherence |
| |
• |
Benefits of adherence monitoring
- Clinical
- Pharma Company
- Other Stakeholders |
Simon Exell
Merck Serono International (CH) |
| |
11:50 am
Addressing Market Needs (e.g. compliance, counterfeiting, child resistancy,
portability...) Successfully throught better Packaging
Peter Reiner
Berndt & Partner (DE) |
| |
12:30 pm
Lunch
|
| |
2:00 pm
Presentation Packaging Award
|
| |
3:00 pm
Panel Discussion
|
| |
3:30 pm
End of Conference
|
| |